Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amicus Therapeutics

5.96
-0.0650-1.08%
Volume:758.03K
Turnover:4.56M
Market Cap:1.83B
PE:-61.95
High:6.11
Open:6.03
Low:5.94
Close:6.02
Loading ...

FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls

Zacks
·
03 May

Amicus Therapeutics Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
03 May

Amicus price target raised to $22 from $21 at UBS

TIPRANKS
·
02 May

UBS Adjusts Amicus Therapeutics Price Target to $22 From $21, Maintains Buy Rating

MT Newswires Live
·
02 May

Why Boss Energy, Capstone, Dimerix, and Platinum shares are storming higher today

MotleyFool
·
02 May

Amicus Therapeutics’ Earnings Call Highlights Growth and Strategic Moves

TIPRANKS
·
02 May

Amicus Therapeutics Down Over 12%, on Pace for Largest Percent Decrease Since January 2022 -- Data Talk

Dow Jones
·
02 May

Amicus (FOLD) Gets a Hold from Needham

TIPRANKS
·
02 May

Amicus Therapeutics Turns to Non-GAAP Q1 Earnings, Revenue Rises; Shares Down

MT Newswires Live
·
01 May

Amicus Therapeutics Shares Down 3.7% Premarket After Q1 REV Miss

THOMSON REUTERS
·
01 May

Earnings Flash (FOLD) Amicus Therapeutics Posts Q1 Revenue $125.2M, vs. FactSet Est of $135.9M

MT Newswires Live
·
01 May

Amicus Therapeutics: Q1 Earnings Snapshot

Associated Press Finance
·
01 May

Amicus reports Q1 non-GAAP EPS 3c, consensus 8c

TIPRANKS
·
01 May

BRIEF-Amicus Therapeutics Q1 Revenue USD 125.2 Million Vs. IBES Estimate USD 135.9 Million

Reuters
·
01 May

Amicus Therapeutics Inc Outlook FY25 Total Revenue Growth 15% to 22%

THOMSON REUTERS
·
01 May

Amicus Therapeutics Inc - Reiterates Gaap Profitability Expectation for H2 2025

THOMSON REUTERS
·
01 May

Amicus Therapeutics Q1 EPS USD -0.07

THOMSON REUTERS
·
01 May

Amicus Therapeutics Q1 Adjusted Operating Expenses USD 94.5 Million

THOMSON REUTERS
·
01 May

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

GlobeNewswire
·
01 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
01 May